BRIAN DAVID HALEVIE-GOLDMAN
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- FAIRFIELD, CA
- NPI
- 1669694857
- Received
- $22,683 in 842 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 132 | $4,092 |
| 2024 | General payment | 107 | $3,531 |
| 2023 | General payment | 125 | $3,535 |
| 2022 | General payment | 108 | $4,022 |
| 2021 | General payment | 141 | $2,854 |
| 2020 | General payment | 80 | $1,441 |
| 2019 | General payment | 149 | $3,205 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 829 | $21,176 |
| Education | 13 | $1,506 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Alkermes, Inc. | $10 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-18 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-12 | Takeda Pharmaceuticals U.S.A., Inc. | $31 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | E.R. Squibb & Sons, L.L.C. | $33 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-05 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | Alkermes, Inc. | $33 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-24 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-24 | Axsome Therapeutics, Inc. | $11 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-11-14 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $34 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $130 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | Vanda Pharmaceuticals Inc. | $8 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-11-05 | Vanda Pharmaceuticals Inc. | $1 | Education | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-03 | Axsome Therapeutics, Inc. | $7 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-29 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-24 | Supernus Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-20 | E.R. Squibb & Sons, L.L.C. | $32 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-20 | Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-10-17 | Otsuka America Pharmaceutical, Inc. | $33 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | Alkermes, Inc. | $6 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-15 | Alkermes, Inc. | $124 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-10 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-26 | Alkermes, Inc. | $30 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-19 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-19 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-19 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-17 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-12 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-10 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-09-05 | Takeda Pharmaceuticals U.S.A., Inc. | $6 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $2 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-09-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $93 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | Takeda Pharmaceuticals U.S.A., Inc. | $30 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | E.R. Squibb & Sons, L.L.C. | $104 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-20 | Otsuka America Pharmaceutical, Inc. | $30 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-06 | Alkermes, Inc. | $3 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-04 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-01 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-07-30 | Alkermes, Inc. | $116 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-07-25 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-23 | Takeda Pharmaceuticals U.S.A., Inc. | $26 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-07-19 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-15 | Alkermes, Inc. | $9 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-14 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-11 | Vanda Pharmaceuticals Inc. | $38 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-07-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-27 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-06-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-21 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-19 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-16 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-09 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-02 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-30 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-23 | Lundbeck LLC | $33 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-17 | Lundbeck LLC | $34 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-15 | Alkermes, Inc. | $112 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-13 | Alkermes, Inc. | $30 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-13 | Bausch Health US, LLC | $24 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-05-09 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $32 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $27 | Education | In-kind items and services | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-29 | Lundbeck LLC | $34 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-23 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-22 | Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-04-21 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-18 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-04-17 | Otsuka America Pharmaceutical, Inc. | $117 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-17 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-14 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-12 | Lundbeck LLC | $34 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-10 | Teva Pharmaceuticals USA, Inc. | $44 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-04-09 | Lundbeck LLC | $29 | Food and Beverage | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-08 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | Alkermes, Inc. | $30 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-03-10 | E.R. Squibb & Sons, L.L.C. | $32 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-07 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-04 | Lundbeck LLC | $35 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-28 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-24 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-24 | Vanda Pharmaceuticals Inc. | $6 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-02-21 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-02-20 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Vanda Pharmaceuticals Inc. | $122 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-02-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-12 | Bausch Health US, LLC | $22 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-02-11 | Lundbeck LLC | $33 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-06 | Janssen Pharmaceuticals, Inc | $34 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-02-05 | Janssen Pharmaceuticals, Inc | $30 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-05 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-02-05 | Vanda Pharmaceuticals Inc. | $1 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-02-03 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-01 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-01-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-23 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-01-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-14 | Bausch Health US, LLC | $24 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-01-09 | Lundbeck LLC | $30 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-08 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2024-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-18 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-12-12 | Lundbeck LLC | $29 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-11 | Lundbeck LLC | $2 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-09 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-05 | Vanda Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-12-04 | E.R. Squibb & Sons, L.L.C. | $112 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-04 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-12-04 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-22 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-11-21 | Lundbeck LLC | $33 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-14 | Alkermes, Inc. | $123 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-11-11 | Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-11-06 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-04 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-11-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-31 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-29 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-25 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-24 | Vanda Pharmaceuticals Inc. | $124 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-24 | Vanda Pharmaceuticals Inc. | $12 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-10-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-17 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-15 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-10-10 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-10-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-04 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-09-27 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-25 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-24 | Lundbeck LLC | $32 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-19 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-09-18 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-09-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-13 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-09-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-04 | Bausch Health US, LLC | $23 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-09-04 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-29 | Bausch Health US, LLC | $22 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-08-28 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-28 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-22 | E.R. Squibb & Sons, L.L.C. | $9 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-08-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-16 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-08-16 | Vanda Pharmaceuticals Inc. | $3 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-08-15 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-07 | Bausch Health US, LLC | $21 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-08-05 | Acella Pharmaceuticals, LLC | $17 | Food and Beverage | In-kind items and services | NP Thyroid 60 Drug, Hyperthyroidism | 2024 | |
| 2024-08-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | Lundbeck LLC | $30 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-16 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-26 | Vanda Pharmaceuticals Inc. | $114 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-06-26 | Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-06-25 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-06-21 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-06-20 | Vanda Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-06-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-06 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-06-05 | Bausch Health US, LLC | $23 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2024 | |
| 2024-06-03 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-03 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-05-30 | Alkermes, Inc. | $25 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-05-20 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-05-17 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-05-14 | Janssen Pharmaceuticals, Inc | $148 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-05-14 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 |
The latest 200 records of 842.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fairfield, CA, county Solano County, CA, state California; placed by its city name.
| Measure | Place (city or town) Fairfield, CA | County Solano County, CA | State California |
|---|---|---|---|
| Population B01003 | 120,785 | 451,918 | 39,287,377 |
| Population, 2020 census P1 | 119,881 | 453,491 | 39,538,223 |
| Median age B01002 | 36.9 | 39.2 | 37.9 |
| Under 18 B01001 | 24.1% | 21.9% | 22.0% |
| 65 and over B01001 | 14.9% | 17.4% | 15.7% |
| Households B11001 | 38,757 | 157,512 | 13,548,091 |
| Foreign born B05002 | 23.3% | 20.8% | 27.0% |
| Median household income B19013 | $101,895 | $100,401 | $99,122 |
| Median family income B19113 | $113,157 | $116,065 | $113,346 |
| Per capita income B19301 | $43,473 | $45,127 | $49,513 |
| Poverty rate B17001 | 10.2% | 10.0% | 12.0% |
| Unemployment rate B23025 | 5.8% | 6.5% | 6.6% |
| Civilian labor force B23025 | 57,778 | 220,729 | 20,068,466 |
| Mean commute (minutes) B08013 | 30.7 | 31.0 | 28.7 |
| Bachelor's degree or higher B15003 | 26.6% | 28.8% | 37.1% |
| Housing units B25001 | 40,391 | 164,693 | 14,644,735 |
| Owner-occupied B25003 | 61.3% | 63.0% | 55.9% |
| Renters B25003 | 38.7% | 37.0% | 44.1% |
| Median home value B25077 | $624,300 | $617,700 | $734,700 |
| Median gross rent B25064 | $2,266 | $2,163 | $2,036 |
| White, not Hispanic B03002 | 26.4% | 33.2% | 33.8% |
| Black B03002 | 14.2% | 12.3% | 5.2% |
| Hispanic or Latino B03002 | 32.7% | 29.6% | 40.2% |
| Asian B03002 | 17.9% | 15.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fairfield, CA.
Comments